Search hospitals > New York > Glens Falls
Glens Falls Hospital
Claim this profileGlens Falls, New York 12801
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lung Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Tumors
149 reported clinical trials
17 medical researchers
Summary
Glens Falls Hospital is a medical facility located in Glens Falls, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Glens Falls Hospital is involved with conducting 149 clinical trials across 355 conditions. There are 17 research doctors associated with this hospital, such as Aqeel A. Gillani, Marie Wood, Alissa Thomas, and Hibba Tul Rehman.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Breast Cancer
Global LeaderER positive
HER2 negative
HER2 positive
Top PIs
Aqeel A. GillaniGlens Falls Hospital4 years of reported clinical research
Studies Cancer
Studies Lung Cancer
11 reported clinical trials
26 drugs studied
Marie WoodUCHealth University of Colorado Hospital3 years of reported clinical research
Studies Breast Cancer
Studies Tumors
9 reported clinical trials
18 drugs studied
Alissa ThomasUniversity of Vermont Medical Center2 years of reported clinical research
Studies Glioblastoma
Studies Lymphoma
8 reported clinical trials
18 drugs studied
Hibba Tul RehmanCentral Vermont Medical Center/National Life Cancer Treatment7 years of reported clinical research
Studies Lung Cancer
Studies Non-Small Cell Lung Cancer
7 reported clinical trials
13 drugs studied
Clinical Trials running at Glens Falls Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Cancer
Prostate Cancer
Diffuse Large B-Cell Lymphoma
Bladder Cancer
Lymphoma
Urothelial Carcinoma
Colorectal Cancer
Chemotherapy + Hormone Therapy
for Breast Cancer
This Phase III Trial will determine whether adjuvant chemotherapy (ACT) added to ovarian function suppression (OFS) plus endocrine therapy (ET) is superior to OFS plus ET in improving invasive breast cancer-free survival (IBCFS) among premenopausal, early- stage breast cancer (EBC) patients with estrogen receptor (ER)-positive, HER2-negative tumors and 21-gene recurrence score (RS) between 16-25 (for pN0 patients) and 0-25 (for pN1 patients).
Recruiting2 awards Phase 319 criteria
Hormone Therapy with or without Radiation
for Breast Cancer
This study is evaluating whether breast conservation surgery and endocrine therapy results in a non-inferior rate of invasive or non-invasive ipsilateral breast tumor recurrence (IBTR) compared to breast conservation with breast radiation and endocrine therapy.
Recruiting2 awards Phase 313 criteria
Shorter Chemo-Immunotherapy Without Anthracyclines
for Breast Cancer
This phase III trial compares the effects of shorter chemotherapy (chemo)-immunotherapy without anthracyclines to usual chemo-immunotherapy for the treatment of early-stage triple negative breast cancer. Paclitaxel is in a class of medications called anti-microtubule agents. It stops cancer cells from growing and dividing and may kill them. Carboplatin is in a class of medications known as platinum-containing compounds. It works in a way similar to the anticancer drug cisplatin, but may be better tolerated than cisplatin. Carboplatin works by killing, stopping or slowing the growth of cancer cells. Cyclophosphamide is in a class of medications called alkylating agents. It works by damaging the cell's deoxyribonucleic acid (DNA) and may kill cancer cells. It may also lower the body's immune response. Docetaxel is in a class of medications called taxanes. It stops cancer cells from growing and dividing and may kill them. Doxorubicin is an anthracycline chemotherapy drug that damages DNA and may kill cancer cells. Pembrolizumab may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Shorter treatment without anthracycline chemotherapy may work the same as the usual anthracycline chemotherapy treatment for early-stage triple negative breast cancer.
Recruiting2 awards Phase 347 criteria
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at Glens Falls Hospital?
Glens Falls Hospital is a medical facility located in Glens Falls, New York. This center is recognized for care of Cancer, Breast Cancer, Lung Cancer, Non-Small Cell Lung Cancer, Tumors and other specialties. Glens Falls Hospital is involved with conducting 149 clinical trials across 355 conditions. There are 17 research doctors associated with this hospital, such as Aqeel A. Gillani, Marie Wood, Alissa Thomas, and Hibba Tul Rehman.